12 November 2021
The Acute Leukemia Advocates Network (ALAN) and Scientific Education Support (SES) are pleased to announce a strategic collaboration for patients with acute leukemias. The aim is to achieve improved disease awareness and education through initiatives using SES’ expertise in communications and medical education and utilising ALAN’s patient leadership in acute leukemias.
Both ALAN and SES have been providing disease awareness & medical education in the acute leukemia patient arena for several years and this has led to the establishing of a collaboration to strengthen initiatives for the benefit of the acute leukemia patient community.
The collaboration which will cover two key areas:
- working together on new patient-focused disease awareness & educational initiatives in a range of acute leukemias involving medical information exchange and dissemination of best practice
- SES will work with ALAN to deliver initiatives that support the ALAN Network members
The initial focus will be on raising awareness in acute lymphoblastic leukemia (ALL) through the launch of Know ALL.
Yvonne Ash, Managing Director of SES said: “We are delighted to be collaborating with ALAN and look forward to working together over the months and years ahead to provide additional support to the already highly effective acute leukemia patient community.
Mikis Euripides, Director of Patient Advocacy Programs at SES said “We pride ourselves on being patient-led, collaborative and informed by the latest science. We have been working with the leukemia patient community informally for several years across a range of hematological disease areas, and this collaboration will enable us to align our evidence-based patient led, educational strategies and activities more closely with ALAN’s goals”.
Zack Pemberton Whiteley, Chair of ALAN: “We are excited about entering into this collaboration to ensure the patient voice is heard across all acute leukemias, starting with the launch of Know ALL. ALAN is the global network for acute leukemia patient organisations and together with SES’ healthcare communications’ expertise, we believe this is a great opportunity.”
Contact details: For any further information please contact Barry Connolly at Science Education Support: email@example.com
Notes To Editor
About The Acute Leukemia Advocates Network (ALAN)
The Acute Leukemia Advocates Network (ALAN) is an independent global network of patient organisations, dedicated to changing outcomes of patients with acute leukemia by strengthening patient advocacy in that area. https://acuteleuk.org/
About Scientific Education Support (SES)
SES is a medical education company with projects such as community physician education through our therapy hubs, community awareness and education through our ‘Know’ education initiatives, and academic researcher education through Entrepreneurs in Clinical Academia (ECA) programs.
Scientific Education Support already has a portfolio of successful websites supporting the advancement of medical education in the field of hemato-oncology, including the ALL Hub, AML Hub, GvHD Hub, Lymphoma Hub, MDS Hub, and MPN Hub.
SES is a medical education provider, building healthcare professional and patient networks that facilitate open access science-driven, unbiased disease education through multichannel communications. https://scientificeducationsupport.com/